DK227487A - Substituerede heterocycliske forbindelser - Google Patents

Substituerede heterocycliske forbindelser

Info

Publication number: DK227487A
Authority: DK; Denmark
Prior art keywords: substituted heterocyclic; heterocyclic compounds; compounds; substituted; heterocyclic
Prior art date: 1986-05-03

Application number

DK227487A

Other languages

English (en)

Other versions

DK227487D0 (da

Inventor

John Berge

Lee James Beeley

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-03

Filing date

1987-05-04

Publication date

1987-11-04

1987-05-04 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1987-05-04 Publication of DK227487D0 publication Critical patent/DK227487D0/da

1987-11-04 Publication of DK227487A publication Critical patent/DK227487A/da

Links

150000001420 substituted heterocyclic compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DK227487A 1986-05-03 1987-05-04 Substituerede heterocycliske forbindelser DK227487A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868610909A GB8610909D0 (en)	1986-05-03	1986-05-03	Compounds

Publications (2)

Publication Number	Publication Date
DK227487D0 DK227487D0 (da)	1987-05-04
DK227487A true DK227487A (da)	1987-11-04

Family

ID=10597340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK227487A DK227487A (da)	1986-05-03	1987-05-04	Substituerede heterocycliske forbindelser

Country Status (12)

Country	Link
US (1)	US4861789A (da)
EP (1)	EP0251453B1 (da)
JP (1)	JPS62267270A (da)
AU (1)	AU600939B2 (da)
DE (1)	DE3767789D1 (da)
DK (1)	DK227487A (da)
ES (1)	ES2031890T3 (da)
GB (1)	GB8610909D0 (da)
GR (1)	GR3001416T3 (da)
NZ (1)	NZ220179A (da)
PT (1)	PT84818B (da)
ZA (1)	ZA873169B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5034406A (en) *	1989-09-26	1991-07-23	Allergan, Inc.	Method for reducing or maintaining intraocular pressure
US5066664A (en) *	1990-02-28	1991-11-19	Allergan, Inc.	2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
DK148292D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Forbindelser
US5580892A (en) *	1993-10-22	1996-12-03	Allergan	Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
US6150389A (en)	1994-07-11	2000-11-21	Allergan Sales, Inc.	Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents
EP0770068B1 (en) *	1994-07-11	2001-11-28	Allergan Sales, Inc.	Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
DE19514579A1 (de)	1995-04-20	1996-10-24	Boehringer Ingelheim Kg	Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5677321A (en) *	1996-02-29	1997-10-14	Synaptic Pharmaceutical Corporation	5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
WO2007093292A2 (en) *	2006-02-15	2007-08-23	Bayer Cropscience Ag	Insecticidal substituted amino heterocyclic and heteroaryl derivatives
EP1988080A1 (en) *	2007-05-03	2008-11-05	Bayer CropScience AG	Insecticidal substituted 2-aminoindanes
WO2008145615A2 (en) *	2007-05-25	2008-12-04	Basf Se	Aminoazoline and urea derivatives for combating animal pests
KR101642520B1 (ko) *	2007-08-15	2016-07-25	알러간, 인코포레이티드	아드레날린성 화합물
KR20100071990A (ko) *	2007-08-15	2010-06-29	알러간, 인코포레이티드	녹내장 및 통증과 같은 질환의 처치에 유용한 헤테로사이클 치환된 융합 카르보사이클
JP2010536780A (ja) *	2007-08-15	2010-12-02	アラーガンインコーポレイテッド	治療化合物
BRPI0906925A2 (pt) *	2008-01-18	2019-09-24	Allergan Inc	agentes adrenérgicos do subtipo alfa 2 seletivos e métodos de uso dos mesmos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2870159A (en) *	1957-07-08	1959-01-20	Pfizer & Co C	Hydrogenated 2-(1-naphthylamino)-oxazolines
US2883410A (en) *	1957-07-08	1959-04-21	Pfizer & Co C	N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas
US2870161A (en) *	1957-07-08	1959-01-20	Pfizer & Co C	2-(1-indanyl amino)-oxazolines
DE1195323B (de) *	1963-06-24	1965-06-24	Thomae Gmbh Dr K	Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen
US3432600A (en) *	1963-09-30	1969-03-11	Du Pont	Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline
US3679798A (en) *	1964-02-28	1972-07-25	Du Pont	Composition comprising arylaminooxazoline and antichloligeneric agent
DE1670751A1 (de) *	1966-09-27	1970-12-23	Bayer Ag	Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) *	1966-09-27	1970-07-16	Bayer Ag	Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
US3882229A (en) *	1972-07-21	1975-05-06	Nordmark Werke Gmbh	Composition and method for shrinking mucous membranes
JPS54151990A (en) *	1978-04-17	1979-11-29	Beiersdorf Ag	Novel condensated nitrogenncontained heterocyclic compound and its manufacture

1986
- 1986-05-03 GB GB868610909A patent/GB8610909D0/en active Pending
1987
- 1987-05-04 PT PT84818A patent/PT84818B/pt not_active IP Right Cessation
- 1987-05-04 US US07/047,720 patent/US4861789A/en not_active Expired - Fee Related
- 1987-05-04 NZ NZ220179A patent/NZ220179A/xx unknown
- 1987-05-04 AU AU72479/87A patent/AU600939B2/en not_active Ceased
- 1987-05-04 ZA ZA873169A patent/ZA873169B/xx unknown
- 1987-05-04 DK DK227487A patent/DK227487A/da not_active Application Discontinuation
- 1987-05-05 DE DE8787304019T patent/DE3767789D1/de not_active Expired - Fee Related
- 1987-05-05 ES ES198787304019T patent/ES2031890T3/es not_active Expired - Lifetime
- 1987-05-05 EP EP87304019A patent/EP0251453B1/en not_active Expired - Lifetime
- 1987-05-06 JP JP62110422A patent/JPS62267270A/ja active Pending
1991
- 1991-01-31 GR GR91400101T patent/GR3001416T3/el unknown

Also Published As

Publication number	Publication date
GR3001416T3 (en)	1992-09-25
DE3767789D1 (de)	1991-03-07
AU600939B2 (en)	1990-08-30
PT84818B (pt)	1989-12-29
NZ220179A (en)	1989-10-27
ZA873169B (en)	1988-04-27
JPS62267270A (ja)	1987-11-19
ES2031890T3 (es)	1993-01-01
AU7247987A (en)	1987-11-05
US4861789A (en)	1989-08-29
PT84818A (en)	1987-06-01
GB8610909D0 (en)	1986-06-11
EP0251453B1 (en)	1991-01-30
DK227487D0 (da)	1987-05-04
EP0251453A2 (en)	1988-01-07
EP0251453A3 (en)	1988-09-28

Legal Events

Date	Code	Title	Description
1992-01-20	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK93887D0 (da)	1987-02-24	Heterocycliske forbindelser
DK321688A (da)	1988-12-25	Heterocykliske forbindelser
DK106786A (da)	1986-09-21	Heterocycliske forbindelser
FI96203C (fi)	1996-05-27	Heterosyklisiä yhdisteitä
FI894960A7 (fi)	1990-04-19	Heterosyklisiä yhdisteitä
DK552685D0 (da)	1985-11-28	Heterocycliske forbindelser
DK162485D0 (da)	1985-04-10	Heterocykliske forbindelser
DK287688D0 (da)	1988-05-25	Heterocycliske forbindelser
DK496086D0 (da)	1986-10-16	Heterocykliske forbindelser
DK219986A (da)	1986-12-01	Nitrogenholdige heterocycliske forbindelser
NO168305C (no)	1992-02-05	Heterocykliske forbindelser
DK64788D0 (da)	1988-02-09	Heterocycliske forbindelser
DK499987D0 (da)	1987-09-23	Heterocycliske forbindelser
FI892038A7 (fi)	1989-10-30	Heterosyklisiä yhdisteitä
DK496885A (da)	1986-05-02	Heterocycliske forbindelser
DK507289A (da)	1990-04-29	Heterocykliske forbindelser
DK429588A (da)	1989-02-04	Heterocykliske forbindelser
DK109586D0 (da)	1986-03-10	Heterocycliske forbindelser
DK397686D0 (da)	1986-08-20	Heterocycliske forbindelser
DK343587A (da)	1988-01-05	Acylerede heterocycliske forbindelser
DK45887D0 (da)	1987-01-28	Heterocykliske forbindelser
DK414886D0 (da)	1986-08-29	Substituerede heterocycliske forbindelser
FI872675A7 (fi)	1987-12-18	Heterocykliska foereningar.
DK565289A (da)	1990-05-12	Heterocykliske forbindelser
LV5744B4 (lv)	1997-02-20	Heterocikliski savienojumi